Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
20:24
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

53rd ERA-EDTA Congress

 

21-24 May 2016 Vienna
FAQs
   
Discussion forum - 53rd ERA-EDTA Congress
    Topic - Genetic diseases and molecular genetics.

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 39
Visits: 24
Title: THE EFFECT OF EVEROLIMUS IN PATIENTS WITH RENAL ANGIOMYOLIPOMA ASSOCIATED WITH TUBEROUS SCLEROSIS COMPLEX
Authors: Roser Torra , Nicolás Roberto Robles, Ramón Peces, Álvaro Gómez-Ferrer, Felipe Villacampa, Jose Luis Álvarez-Ossorio, Pedro Pérez, Enrique Trilla, Bernardo Herrera, Javier Nieto, Joaquín Carballido, Urbano Anido, Cristina Meseguer, and Roser Torra
Centre: Fundació Puigvert

You must be registered to reply or comment.

THE EFFECT OF EVEROLIMUS IN PATIENTS WITH RENAL ANGIOMYOLIPOMA ASSOCIATED WITH TUBEROUS SCLEROSIS COMPLEX

Roser Torra
Thread initiator
Subspeciality
Reg: 9/26/2008 2:46:00 PM

Comment# 1

I invite healthcare professionals to open debate around the issues raised in my poster, both those relating to research and to clinical practice.

Comment added on 5/6/2016 12:18:00 PM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 547
Visits: 1241
Title: COMPARISON OF PATIENT HAEMOGLOBIN OUTCOMES WITH WEEKLY IRON ADMINISTRATION VS PER SESSION IRON ADMINISTRATION IN ADULT HAEMODIALYSIS PATIENTS
Authors: Joao Fazendeiro , Ricardo Peralta, Carla Felix, Bruno Pinto, Ilidio Rodrigues, Carlos Oliveira, Anibal Ferreira, Pedro Ponce
Centre: Fresenius Medical Care Portugal

Poster most viewed in this topic
Poster: 60
Visits: 24
Title: DETERMINING TREATMENT PREFERENCE FOR TOLVAPTAN IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD): DEVELOPMENT OF A DISCRETE CHOICE EXPERIMENT (DCE) FOR USE AS A CLINICAL STUDY ENDPOINT
Authors: Jennifer Quinn , Helen Doll, Paul Robinson, Hannah Lewis
Centre: Otsuka Pharmaceuticals


 






PosterSessionOnline
Logo Draft
 
Logo Cert